Metraipolis › archive › dc_8090810463b4

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno… — Europe PMC PMID:41385757

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41385757
DOI
10.1200/jco-25-01868
License (as archived)
solo-consultazione
Archived
2026-10-07T15:49:41.992Z
SHA-256 of the archived text
d9d401c4aec6362cd79c900654a3b32e7c346249fe3d07d359f9782dd691b96c
Stable URL of this page
https://metraipolis.com/documento/dc_8090810463b4

How to cite

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno… — Europe PMC PMID:41385757 — Europe PMC (en), https://europepmc.org/article/MED/41385757 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8090810463b4 (Metraipolis archive dc_8090810463b4, sha256 d9d401c4aec6362cd79c900654a3b32e7c346249fe3d07d359f9782dd691b96c)
BibTeX
@misc{dc8090810463b4,
  title = {Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno… — Europe PMC PMID:41385757},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41385757},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8090810463b4; sha256 d9d401c4aec6362cd79c900654a3b32e7c346249fe3d07d359f9782dd691b96c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41385757. Agents can read the archived copy with the MCP tool read_document.